HALO (Halozyme Therapeutics) Pangali Forward P/E

Simbol resmi perusahaan Halozyme (HALO)

Halozyme Therapeutics (HALO) possesses a colossal liquidity reserve thanks to a low-cost royalty collection model. Business revenues are independent of economic cycles or seasonality, demonstrating resilience to shocks. The environmental focus is directed toward reducing medical waste. The trend of the company's forward P/E reflects a shift in market valuations, and the value of 9.40 shows the current magnitude of this indicator.

Halozyme - Pangali Forward P/E HALO (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis Halozyme Therapeutics (HALO)

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental:Halozyme Therapeutics, Inc.
Produk merek Halozyme Corp

Forward P/E measures the current stock price relative to expected earnings for the following year. Analyzing the consensus forward P/E of a company allows investors to filter out market noise, revealing the actual overvaluation or undervaluation of assets. This chart reflects the market's confidence in future cash flows. For Halozyme Therapeutics (HALO), this indicator confirms the resilience of the ENHANZE technology licensing model. Stable royalties from pharma behemoths make earnings forecasts predictable, thereby reducing investment risks.

Analisis perusahaan pesaing

Pangali Forward P/E ONC|RVMD (RevMed) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AAPG (ascentage.com)|CGON - Prakiraan rega marang bathi|URGN: Prakiraan rega marang bathi|BCAX - Pangali Forward P/E|Personalis Corp (PSNL) - Rega marang bathi mangsa ngarep|Erasca Corp - Pangali mangsa ngarep rega marang bathi|DCTH (Delcath Systems Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Y-mAbs Therapeutics, Inc. YMAB|Pangali Forward P/E AURA|Prakiraan rega marang bathi Candel Therapeutics, Inc. CADL|Pangali Forward P/E ARAY (Accuray, Inc.)|SELLAS Life Sciences - Rega marang bathi mangsa ngarep|ACTU: Prakiraan rega marang bathi|Citius Oncology, Inc. - Rasio kapitalisasi marang bathi mangsa ngarep|HURA (TuHURA Biosciences) - Prakiraan rega marang bathi|TARA: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi FATE|WHWK: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi TCRX (TScan Therapeutics Inc)|Kapitalisasi marang proyeksi bathi Champions Oncology Inc|Pangali Forward P/E XBIT (XBiotech Inc.)|Pangali mangsa ngarep rega marang bathi CVM|OS Therapies Inc. - Pangali Forward P/E|RADX - Pangali Forward P/E|ARTV: Pangali Forward P/E|ANL: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep xiliotx.com (XLO)|Renovaro - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA - Prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC - Pangali Forward P/E|Curis, Inc. (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics, Inc.|Prakiraan rega marang bathi THAR|Rasio rega marang bathi mangsa ngarep ADVB (Advanced Biomed)|Prakiraan rega marang bathi GNPX (Genprex, Inc)|CLDI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep sunshinebiopharma.com SBFM|XBIO - Prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|Purple Biotech - Rasio kapitalisasi marang bathi mangsa ngarep|American Oncology Network (AONC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep BGNE|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E